Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone Supplementation for Early MIPS in Basal Ganglia ICH
NCT05582707Phase 2Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in intracerebral hemorrhage (ICH), sponsored by University of Maryland, Baltimore. Started May 2023; status: terminated.
02
Drugs
pioglitazone
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05582707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05582707.